NASDAQ:PETS - Nasdaq - US7163821066 - Common Stock - Currency: USD
PETMED EXPRESS INC
NASDAQ:PETS (2/10/2025, 8:17:24 PM)
Premarket: 4.14 -1.13 (-21.44%)5.27
-0.05 (-0.94%)
The current stock price of PETS is 5.27 USD. In the past month the price increased by 10.48%. In the past year, price increased by 1.15%.
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
DELRAY BEACH, Fla., Feb. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its...
DELRAY BEACH, Fla., Dec. 03, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) (“PetMeds” or the...
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TSCO | TRACTOR SUPPLY COMPANY | 26.68 | 29.08B | ||
DKS | DICK'S SPORTING GOODS INC | 16.58 | 19.28B | ||
ULTA | ULTA BEAUTY INC | 15.06 | 17.45B | ||
CHWY | CHEWY INC - CLASS A | 118 | 15.38B | ||
BBWI | BATH & BODY WORKS INC | 10.75 | 7.68B | ||
FIVE | FIVE BELOW | 17.28 | 4.95B | ||
ASO | ACADEMY SPORTS & OUTDOORS IN | 8.39 | 3.67B | ||
WRBY | WARBY PARKER INC-CLASS A | 115.78 | 3.20B | ||
SIG | SIGNET JEWELERS LTD | 5.81 | 2.36B | ||
UPBD | UPBOUND GROUP INC | 8.22 | 1.61B | ||
WINA | WINMARK CORP | 29.08 | 1.36B | ||
SBH | SALLY BEAUTY HOLDINGS INC | 5.66 | 980.64M |
PetMed Express, Inc. engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. The company is headquartered in Delray Beach, Florida and currently employs 287 full-time employees. The company went IPO on 2000-04-06. The firm is an online provider of prescription and non-prescription medications, food, supplements, and supplies and has veterinary and pet insurance service partnerships for dogs, cats, and horses. The company markets and sells directly to consumers through their Websites, toll-free numbers, and employer benefit partnerships. Its product line contains over 15,000 SKUs of pet medications, health products, foods, and supplies. The firm offers various pet supplies, including beds, crates, stairs and other pet supplies. Its products include Prescription Medications (Rx), Non-Prescription Medications (OTC) and supplies, Pet Foods, Private Label and Holistic Wellness Services. Rx includes heartworm and flea and ticks preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
PETMED EXPRESS INC
420 South Congress Avenue
Delray Beach FLORIDA 33445 US
CEO: Menderes Akdag
Employees: 287
Company Website: https://www.1800petmeds.com/
Investor Relations: https://www.1800petmeds.com/who-we-are/who-we-are-investors.html
Phone: 15614264444
The current stock price of PETS is 5.27 USD.
The exchange symbol of PETMED EXPRESS INC is PETS and it is listed on the Nasdaq exchange.
PETS stock is listed on the Nasdaq exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for PETS, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of PETS.
PETS does not pay a dividend.
The PE ratio for PETS is 527. This is based on the reported non-GAAP earnings per share of 0.01 and the current share price of 5.27 USD.
The outstanding short interest for PETS is 8% of its float.
ChartMill assigns a technical rating of 7 / 10 to PETS. When comparing the yearly performance of all stocks, PETS turns out to be only a medium performer in the overall market: it outperformed 61.88% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to PETS. While PETS has a great health rating, there are worries on its profitability.
Over the last trailing twelve months PETS reported a non-GAAP Earnings per Share(EPS) of 0.01. The EPS increased by 102.56% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -0.66% | ||
ROE | -1% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 43% to PETS. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 144.46% and a revenue growth -7.88% for PETS